Fluoroquinolone-induced tendinopathy: Subjects at risk pathophysiological mechanisms incriminated, therapeutic management;Les tendinopathies liées aux fluoroquinolones : Les sujets à risque, les mécanismes physiopathologiques incriminés, la prise en charge thérapeutique

Progres en Urologie

Volumn 11, Issue 6, 2001, Pages 1331-1334

  Saint, Fabien ^a   Salomon, Laurent ^a   Cicco, Antony ^a   De La Taille, Alexandre ^a   Chopin, Dominique ^a   Abbou, Clément Claude ^a  

^a HENRI MONDOR HOSPITAL   (France)

Author keywords

Fluoroquinolone; Tendinopathy; Tendon rupture

Indexed keywords

ANTIINFECTIVE AGENT; QUINOLONE DERIVATIVE;

CHEMICALLY INDUCED DISORDER; HUMAN; MUSCLE DISEASE; PATHOPHYSIOLOGY; REVIEW; RISK FACTOR; RUPTURE; TENDON; URINARY TRACT INFECTION;

ANTI-INFECTIVE AGENTS; FLUOROQUINOLONES; HUMANS; MUSCULAR DISEASES; RISK FACTORS; RUPTURE, SPONTANEOUS; TENDONS; URINARY TRACT INFECTIONS;

EID: 0347711981     PISSN: 11667087     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. BAILEY R.R., KIRK J.A., PEDDIE B.A.: Norfloxacin induced rheumatic disease. New Zealand Med J., 1983, 96 : 590.
2. BERNARD-BEAUBOIS K., HECQUET C., HAYEM G., RAT T., ADOLPHE M. In vitro study of cytotoxicity of quinolones on rabbit tenocytes. Cell. Biol. Toxicol., 1998 ; 14, 283-292.
3. BERTINO J., FISH D. The safety profile of the fluoroquinolones. Clin. Ther. 2000, 22, 798-817.
4. GILLET P., BLUM A., HESTIN D., POUREL J., PIERFITTE C., MAINARD D., KESSLER M., NETTER P.: Magnetic resonance imaging may be an asset to diagnose and classify fluoroquinolone associated Achilles tendinitis. Fundam. Clin. Pharmacol., 1995, 9 : 52-56.
5. HEYD A., HAVERSTOCK D. Retrospective analysis of safety profile of oral and intravenous ciprofloxacin in a geriatric population. Clin. Ther., 2000, 22 : 1239-1250.
6. JULIAN B.A., QUARLES L.D., NIEMANN K.M.W. Musculoskeletal complications after renal transplantation : pathogenesis and treatment. Am. J. Kidne. Dis., 1992, 19 : 99-120.
7. KASHIDA Y., KATO M. Characterization of fluoroquinolone induced Achilles tendon toxicity in rats: comparison of toxicities of 10 fluoroquinolones and effects of anti-inflammatory compounds. Antimicrob. Agents Chemother., 1999, 41 : 2389-2393.
8. KOEGER A.C: Tendinite lors d'un traitement par fluoroquinolones. Rev. Prat., 1996, 10 : 66-79.
9. Le HUEC J.C., SCHAEVERBEKE T., CHAUVEAUX F. RIVEL J., DEHAIS J., Le REBELLER A.: Epicondylitis after treatment with fluoroquinolone antibiotics. J. Bone Joint Surg., 1995, 77: 293-295.
10. MOVIN T., GAD A., GUNTNER P., FOLDHAZY Z., ROLF C.: Pathology of the Achille tendon in association with ciprofloxacin treatment. Foot and Ankle, 1997, 18: 297-299.
11. ROYER R.J., PIERFITTE C., NETTER P.: Features of tendon disorders with fluoroquinolones. Therapie, 1994, 49: 75-76.
12. SAINT F., GUEGUEN G., BISERTE J., FONTAINE C., MAZEMAN E. Rupture du ligament patellaire un mois après traitement pour fluoroquinolone. Revue de chirurgie orthopédique, 2000, 86 : 495-497.
13. SHAKIBAEI M., PFISTER K., SCHWABE R., VORMANN J., STAHLMANN R. Ultrastructure of Achilles tendons of rats treated with ofloxacin and fed a normal or megnesium-deficient diet. Antimicrob. Agent Chemother., 2000, 44, 261-266.
14. SIMONIN M.A., GEGOUT-POTTIE P., MINN A., GILLET P., NETTER P., TERLAIN B. Proteoglycan and collagen biochemical variations during fluoroquinolone induced chondrotoxicity in mice. Antimicrob. Agents Chemother., 1999, 43 : 2915-2921.
15. WILLIAM R.J., AHIA E., WICKIEWICZ T.L., HANNAFIN J.A. The effect of ciprofloxacine on tendon and paratendon, and capsular fibroblast metabolism. Am. J. Sports Med., 2000, 28 : 364-369.